Health Care/Hospital
Ocumension Therapeutics Launches Initial Public Offering on Hong Kong Stock Exchange
SHANGHAI, July 10, 2020 /PRNewswire/ -- Ocumension Therapeutics ("Ocumension"), aChina-based ophthalmic pharmaceutical platform company, has today launched its Initial Public Offering (IPO) of the company's stock on The Stock Exchange of Hong Kong (HKEX). Ocumension plans to offer 105,930,000 shar...
2020-07-10 21:55
19739
China Jo-Jo Drugstores Reports Fiscal Year 2020 Financial Results
HANGZHOU, China, July 10, 2020 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its fina...
2020-07-10 21:00
17309
CS02 Changes the Landscape of Diabetes Treatment: CenterLab Announces Positive Topline Results of Phase 2 Trial
TAIPEI, July 10, 2020 /PRNewswire/ -- Center Laboratories Inc. (CenterLab: 4123.TWO), a pharmaceutical company dedicated in specialty drug product development, announced today that the anti-diabetic drug – CS02 meets its primary endpoint. The topline results of a phase 2 clinical trial of CS02...
2020-07-10 20:43
3654
Zhongchao Inc. Co-organizes China-Russia-Near East Gastrointestinal Academic Dialogue
SHANGHAI, July 10, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-organized a virtual panel ses...
2020-07-10 18:30
3563
Sedana Medical Announces Positive Top Line Result in Pivotal IsoConDa Study
STOCKHOLM, July 10, 2020 /PRNewswire/ -- Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced a positive top line result for the company's pivotal phase III study, IsoConDa. The study reached its primary endpoint; to show that IsoConDa (isoflurane), administered with AnaConDa, is an ef...
2020-07-10 13:32
1518
Merck Opens its Largest M Lab™ Collaboration Center in Shanghai
-- Focus on improving and optimizing drug discovery, development and manufacturing -- Integrated lab with customizable solutions, validation services, training and hands-on applications -- Shanghai center is newest and largest addition to Merck's global network of nine M Lab™ Collaboration Cente...
2020-07-10 13:00
3086
Carromex Unveils Pharma Leads, a Groundbreaking Cloud-based Platform for Rapid Drug Analysis and Discovery
SYDNEY and MELBOURNE, Australia, July 9, 2020 /PRNewswire/ -- Carromex, a
mathematical research-based innovation company based inAustralia, unveiled a
new cloud-based pharmaceutical software platform called Pharma Leads
https://carromex.com/products/pharma-leads/
2020-07-10 11:31
1134
PolyU discovers the effect of chemical compound PTU on autophagy in zebrafish embryos, sheds light on cancer medication research
HONG KONG, July 10, 2020 /PRNewswire/ -- The zebrafish has been utilised as a model organism for biomedical research globally for half a century, mainly due to the high genetic similarity (over 70%) between zebrafish and human genes, with over 80% of human morbid genes related to at least one zeb...
2020-07-10 10:18
2337
Q Division Bringing Emerging Technology Expertise to Advanced Materials Pandemic Task Force
DAYTON, Ohio, July 9, 2020 /PRNewswire/ -- Q Division today announced their participation as commercial retail experts in the global Advanced Materials Pandemic Task Force (AMPT) - an international public-interest initiative focused on using Advanced Materials to solve some of humanity's most pre...
2020-07-09 22:00
1810
Laboratory Studies Confirm BETADINE(R) Antiseptic Products' Effectiveness Against COVID-19 Virus
SINGAPORE, July 9, 2020 /PRNewswire/ -- Mundipharma today announced that laboratory testing at the Duke-NUS Medical School in Singapore, has confirmed the effectiveness of its BETADINE® antiseptic products against the novel coronavirus (SARS-CoV-2) which causes COVID-19 disease. Testing has demo...
2020-07-09 21:27
3719
Frost & Sullivan Recognizes DrFirst for Solutions Providing Secure Communication, Collaboration, and Real-Time Access to Patient Information at the Point of Care
DrFirst wins Digital Health Data Industry New Product Innovation Award for its suite of products that improve healthcare providers' clinical view of patients' medical information and drug regimens SANTA CLARA, California, July 9, 2020 /PRNewswire/ -- Providers across multiple care settings requi...
2020-07-09 21:00
1581
New Report Reviews Global Hospital Practices in Pandemic Flu Response
SINGAPORE, July 9, 2020 /PRNewswire/ -- Eden Strategy Institute today unveiled a global review of hospital practices in dealing with flu pandemic, drawing novel and interesting insights from the current COVID-19 pandemic as well as from previous pandemics such as SARS, H1N1, and Ebola. This rese...
2020-07-09 17:19
1844
WuXi AppTec to Launch a Special Webinar on Collaborations that Transform on July 16 | Advances in Rare Diseases: Hemophilia
SHANGHAI and SAN DIEGO, July 9, 2020 /PRNewswire/ -- WuXi AppTec is pleased to announce that they are about to launch the second session of the webinar series "Collaborations That Transform," highlighting the impact of partnerships in bringing effective therapies to patients. This complimentary w...
2020-07-09 16:32
1441
AGC Biologics Collaborates with Molecular Partners AG to Develop Anti-COVID-19 DARPin® Program
SEATTLE, July 9, 2020 /PRNewswire/ -- Global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)AGC Biologics is partnering with clinical-stage biotech companyMolecular Partners AG to develop a new class of custom-built protein therapeutics known as DARPin®. AGC Biologics...
2020-07-09 13:00
2469
Men Are Discreet About Their Negative Body Confidence and Self-perception, Observes Dr Ivan Puah, Medical Director Of Amaris B. Clinic
SINGAPORE, July 9, 2020 /PRNewswire/ -- Dr Ivan Puah, Medical Director of Amaris B. Clinic, is seeing an increasing number of males seeking treatment for gynecomastia and surgical reduction of localised fat in recent years due to body dissatisfaction. Men, just like women, do care about their ...
2020-07-09 12:30
3090
Innovent Announces First Patient Dosed in a Phase 1b Clinical Trial of Sintilimab plus Surufatinib in Advanced Malignancies in China
SUZHOU, China, July 9, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today anno...
2020-07-09 08:00
12007
Paige Applauded by Frost & Sullivan for its Leading AI-based Computational Pathology Offering that Enables Fast and Accurate Cancer Diagnoses
Paige leveraged the world's largest dataset in pathology to develop an unparalleled computation pathology offering SANTA CLARA, California, July 8, 2020 /PRNewswire/ -- Based on its recent analysis of the North American AI-based digital pathology market, Frost & Sullivan recognizesPaige with the...
2020-07-08 23:40
1673
Asieris Received China NMPA's Approval to Start a Global Phase III Clinical Trial for APL-1702 to Treat Cervical Precancerous Lesions (HSIL)
SHANGHAI, July 8, 2020 /PRNewswire/ -- Asieris Pharmaceuticals (Asieris), a China-based biotech company with global aspirations to discover, develop and commercialize innovative drugs for the treatment of genitourinary tumors and related diseases, announced today it has received Clinical Trial Ap...
2020-07-08 22:00
1244
Frost & Sullivan Honors Leading Organizations in Asia-Pacific in an Inaugural Virtual Ceremony for the 2020 Asia-Pacific Best Practices Awards
SINGAPORE, July 8, 2020 /PRNewswire/ -- Frost & Sullivan honored Asia-Pacific's leading companies at the18th annual Asia-Pacific Best Practices Awards on 8 July in an inaugural virtual awards ceremony. A total of15 awards were presented to organizations for elevating performance benchmarks and fo...
2020-07-08 19:03
1770
Lipidor Signs Agreement With CRO for Implementation of Phase III Clinical Study of Drug Candidate AKP-02 Against Psoriasis
STOCKHOLM, July 8, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North: LIPI) today announced an agreement with Cadila Pharmaceuticals, a leading Indian pharmaceutical company with extensive CRO capacity, to conduct a Phase III study for Lipidor's drug candidate AKP-02. The study is expected to c...
2020-07-08 14:57
1589
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2928
